Assertio Holdings Inc ASRT:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/03/24 EDT
1.04quote price arrow up+0.01 (+0.95%)
Volume
25,492
Close
1.03quote price arrow up+0.02 (+1.98%)
Volume
572,153
52 week range
0.73 - 8.01
Loading...
  • Open1.01
  • Day High1.04
  • Day Low0.99
  • Prev Close1.01
  • 52 Week High8.01
  • 52 Week High Date05/11/23
  • 52 Week Low0.73
  • 52 Week Low Date04/25/24

Key Stats

  • Market Cap97.976M
  • Shares Out95.12M
  • 10 Day Average Volume1.07M
  • Dividend-
  • Dividend Yield-
  • Beta0.90
  • YTD % Change-3.74

KEY STATS

  • Open1.01
  • Day High1.04
  • Day Low0.99
  • Prev Close1.01
  • 52 Week High8.01
  • 52 Week High Date05/11/23
  • 52 Week Low0.73
  • 52 Week Low Date04/25/24
  • Market Cap97.976M
  • Shares Out95.12M
  • 10 Day Average Volume1.07M
  • Dividend-
  • Dividend Yield-
  • Beta0.90
  • YTD % Change-3.74

RATIOS/PROFITABILITY

  • EPS (TTM)-3.97
  • P/E (TTM)-0.26
  • Fwd P/E (NTM)-8.58
  • EBITDA (TTM)44.501M
  • ROE (TTM)-182.52%
  • Revenue (TTM)152.069M
  • Gross Margin (TTM)82.36%
  • Net Margin (TTM)-218.28%
  • Debt To Equity (MRQ)27.91%

EVENTS

  • Earnings Date05/06/2024
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Assertio Holdings Inc

 

Profile

MORE
Assertio Holdings, Inc. is a commercial pharmaceutical company offering differentiated products to patients. The Company has built its commercial portfolio through acquisition or licensing of approved products. Its comprehensive commercial capabilities include marketing through both a sales force and a non-personal promotion model, market access through payor contracting and trade and distribution. The Company’s primary marketed products include ROLVEDONTM...
Peter Staple
Independent Chairman of the Board
Heather Mason
Interim Chief Executive Officer, Director
Ajay Patel
Chief Financial Officer, Senior Vice President, Chief Accounting Officer
Address
100 S. Saunders Road, Suite 300
Lake Forest, IL
60045
United States

Top Peers

SYMBOLLASTCHG%CHG
SCYX
SCYNEXIS Inc
1.77-0.01-0.56%
ACORQ
Acorda Therapeutics Inc
0.85UNCHUNCH
AYTU
Aytu Biopharma Inc
3.01UNCHUNCH
OPTN
OptiNose Inc
1.01+0.13+15.09%
MEIP
MEI Pharma Inc
3.06UNCHUNCH